← Leaderboards
Daniel J. Sexton
Duke University
$2,749,818
Attributed
$2,749,818
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
CDC$2,749,818 · 2
By mechanism
U54$2,749,818 · 1
R01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Kenneth G. Manton$25,808,973
- Kenneth A Dodge$42,207,577
- Helene D Benveniste$9,482,079
- Frank Sloan$9,580,143
- Redford B Williams$23,495,063
Research focus
Disease /Disorder Proneness /RiskHealth Care Cost /FinancingModel Design /DevelopmentPatient Safety /Medical Error
Grant awards (7)
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$760,243
U54 · FY2015 · CK · contact PI
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$397,915
U54 · FY2015 · CK · contact PI
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$397,915
U54 · FY2014 · CK · contact PI
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$397,915
U54 · FY2013 · CK · contact PI
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$397,915
U54 · FY2012 · CK · contact PI
A Four-arm Prospective, Multicenter Study to Assess the Clinical Efficacy, Effect$397,915
U54 · FY2011 · CK · contact PI
Applied Research on Antimicrobial Ressitance$0
R01 · FY2005 · CI